The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir - STAT
Last Updated: 25.06.2025 18:05
On Thursday, the FDA approved lenacapavir, to be sold as Yeztugo, for the prevention of HIV in the U.S. The below essay, adapted from Breakthrough: The Quest for Life-Changing Medicine by William Pao… [+37025 chars]